Sign In
Section Navigation
Common TitleDELPHI
Official Title A Phase II, Open-label Trial, to Investigate Pharmacokinetics, Safety, Tolerability and Antiviral Activity of (Darunavir)TMC114/Ritonavir b.i.d in Treatment-Experienced HIV-1 Infected Children and Adolescents
Phase Phase II
ClinicalTrials.gov NCT00355524
Categories PediatricsTreatment-Experienced
Funding
IndustryTibotec Pharmaceuticals, Ireland
References
  • Blanche S, Bologna R, Cahn P, et al. Pharmacokinetics, safety and efficacy of darunavir/ritonavir in treatment-experienced children and adolescents. AIDS. 2009;23:2005-13.
    [PubMed Abstract]

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.